logo
Trump Administration Live Updates: Lawyers Request Release of Salvadoran Man Until Trial

Trump Administration Live Updates: Lawyers Request Release of Salvadoran Man Until Trial

New York Times12-06-2025
Health Secretary Robert F. Kennedy Jr. on Wednesday named eight doctors and researchers, including four who have spoken out against vaccination in some way, to replace roughly half the members he fired from an expert panel that advises the Centers for Disease Control and Prevention.
Mr. Kennedy made the announcement Wednesday on the social media platform X, two days after he fired all 17 members of the Advisory Committee on Immunization Practices. Arriving at the John F. Kennedy Center for the Performing Arts for a performance of 'Les Misérables' that President Trump also attended, the health secretary told reporters that the firings were 'a long time coming.'
Mr. Kennedy said on X that his picks included 'highly credentialed scientists, leading public-health experts, and some of America's most accomplished physicians.' In a post on X late Tuesday night, a day after he removed the panel members, Mr. Kennedy promised he would not appoint 'ideological anti-vaxxers.'
After the new list was announced, infectious disease and vaccine experts immediately accused the health secretary of breaking his word. When Mr. Kennedy fired the entire committee, known as the A.C.I.P., he cited financial conflicts of interest and said a clean sweep was necessary to restore public trust in vaccination.
But a White House official and a person close to Mr. Kennedy said on Tuesday that ideology was also at work. In addition to supposed financial conflicts, Mr. Kennedy was concerned that all of the members had been appointed by former President Joseph R. Biden Jr., and that some had donated to Democrats. The disclosure was shocking to public health leaders, who say that scientific advisers are chosen for their expertise, without consideration of party affiliation.
'The biggest hit here is the irony of him, RFK, talking about regaining the public's trust,' said Dr. Paul Offit of the Children's Hospital of Philadelphia, who has served as a committee member and has frequently tangled with Mr. Kennedy.
'What he just did was, he lost the trust of the medical community,' Dr. Offit added, 'so much so that people are thinking, 'Should we try and create our own A.C.I.P., our own vaccine advisory committee?' Because you can't trust this one.'
The eight members Mr. Kennedy named — seven men and one woman — have varied credentials. All are either medical doctors or have doctorates. They include a psychiatrist; a biostatistician; an expert in health care analytics; a biochemist; a pediatrician; an emergency medical doctor; a public health and critical care nurse; and an obstetrician.
Richard H. Hughes IV, who teaches vaccine law at George Washington University Law School, called out one of the new committee members — Dr. Cody Meissner — as a 'legitimate vaccinologist.' Dr. Meissner, a professor of pediatrics at Dartmouth, has previously held advisory roles both with the C.D.C. and the Food and Drug Administration. Dr. Offit and other experts praised Dr. Meissner for his depth of knowledge about vaccines.
Mr. Hughes said three of the new members are 'legitimate physicians' who have 'no discernible expertise' in immunology or vaccines. But he characterized the remaining four as 'Covid-19 deniers, skeptics and outright anti-vaccine individuals.'
By far the most contentious pick, and the one with the highest profile, is Dr. Robert Malone. He played an early role in mRNA research and has claimed to be the inventor of the technology. He became a right-wing star after a 2021 appearance on 'The Joe Rogan Experience' that exposed both him and Mr. Rogan to criticism that they had spread misinformation. Dr. Malone was a vocal critic of the Biden administration's Covid response.
'Malone has a well-documented history of promoting conspiracy theories and unproven treatment like ivermectin and hydroxychloroquine for Covid-19,' said Dr. Jeffrey D. Klausner, an epidemiologist and infectious disease expert at the University of Southern California.
Dr. Klausner, who is also a neighbor of Mr. Kennedy's in Los Angeles and has spoken with the health secretary about possible candidates for advisory committees, said he was 'disappointed' in Dr. Malone's appointment, which he said was likely 'a political move to maintain support of some Americans and demonstrate diversity, equity and inclusivity.'
Martin Kulldorff, a Swedish biostatistician and former Harvard professor, has been generally supportive of vaccines, and has advised the C.D.C. on vaccine safety. But he opposed Covid vaccine mandates and Covid vaccination for children, and became caught up in pandemic politics in 2020 as a lead author of the Great Barrington Declaration, a document that opposed lockdowns.
The declaration, whose lead authors also included Dr. Jay Bhattacharya, the current director of the National Institutes of Health, garnered nearly one million signatures from more than 40 countries. Dr. Meissner, the new A.C.I.P. member, was an early signer. But it drew intense backlash from Dr. Anthony S. Fauci and other public health leaders, who branded it dangerous.
Dr. Francis S. Collins, the N.I.H. director at the time, called the authors 'fringe epidemiologists.'
Dr. Kulldorff was later fired from his hospital, Mass General Brigham, and from Harvard, in a dispute over the hospital's requirement for staff to be vaccinated against Covid-19. He has said that he has an immune deficiency, which made him wary of the Covid shot, and that he already had natural immunity from a previous infection.
While Dr. Malone and Dr. Kulldorff are the best known of the new members, two other picks — Retsef Levi and Vicky Pebsworth, a nurse — are also likely to come under scrutiny from public health leaders.
Dr. Levi, an expert in analytics, risk management and health systems at the Massachusetts Institute of Technology, has criticized school closures and Covid lockdowns, and warned against mRNA vaccines.
In a 2023 post on X, he wrote, 'The evidence is mounting and indisputable that mRNA vaccines cause serious harm including death, especially among young people.' He has said the evidence for vaccinating against Covid-19 in pregnancy 'is particularly thin.'
After Mr. Kennedy's announcement, Dr. Levi said on Wednesday on X that he was 'honored with this opportunity and humbled by the responsibility' to serve on the panel.
Dr. Pebsworth, who has a Ph.D. in public health, serves on the board of the National Vaccine Information Center, founded in 1982 to promote awareness of the risks of vaccination. She has served as a consumer representative to an expert panel that advises the F.D.A. on vaccination and has advised the government in other capacities.
In its early years, the vaccine information center worked with federal authorities to promote vaccine safety, and to create a system to address vaccine injuries. But today, advocates for vaccination consider it an anti-vaccine group.
Dr. Pebsworth's bio on the center's website says she is the parent of a vaccine-injured child. 'Her son — her only child — experienced serious, long-term health problems following receipt of seven live virus and killed bacterial vaccines administered during his 15-month well-baby visit, which sparked her interest in vaccine safety research and policymaking, and chronic illness and disability in children,' the site says.
It is unclear how the committee will move forward with an entirely new membership. Its next meeting is set for later this month. Committee members had expected to discuss, among other things, a change in the vaccination schedule for the human papillomavirus vaccine, but it does not appear as though there is an agenda on the committee's website.
'This is a very differently constituted committee than what we've had before,' said Dr. Yvonne Maldonado, a pediatrician and professor at Stanford University who was among the members fired on Monday. She predicted it would be 'very difficult to get through the agenda in a smooth way,' given that the new panel will have only two weeks to prepare.
Javier C. Hernández and Apoorva Mandavilli contributed reporting,
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US government turmoil stalls thousands of export approvals, sources say
US government turmoil stalls thousands of export approvals, sources say

Yahoo

time27 minutes ago

  • Yahoo

US government turmoil stalls thousands of export approvals, sources say

By Karen Freifeld and Alexandra Alper (Reuters) -Thousands of license applications by U.S. companies to export goods and technology around the globe, including to China, are in limbo because turmoil at the agency in charge of approving them has left it nearly paralyzed, two sources said. While U.S. Commerce Secretary Howard Lutnick has become a familiar face touting President Donald Trump's tariff and trade deals, sources said the export bureau under Lutnick's command has failed to issue expected new rules, stifled communications with industry representatives, pushed out experts, and lost staff through buyouts and resignations. Shipments of artificial intelligence chips from Nvidia to China are the most high-profile example of licenses not being swiftly approved. The company said July 14 the government assured it licenses would be granted for its H20 chip, and it hoped to start deliveries soon. Lutnick and other officials confirmed sales would be allowed. But sources said this week no licenses have yet been issued, and billions of dollars of AI chip orders are at stake. One U.S. official said the backlog of license applications is the lengthiest in more than three decades. A spokesperson for Nvidia declined to comment. The Department of Commerce did not respond to a request for comment. The turmoil and resulting inaction at an agency tasked with promoting overseas trade and safeguarding American technology are alarming both those seeking tougher restrictions on exports to China and companies trying to sell their wares abroad. 'Licensing is how the U.S. does business and competes globally,' said Meghan Harris, who served on the National Security Council in the first Trump administration and has worked at Commerce. "Delays and unpredictability put us at an unnecessary disadvantage." The Commerce Department's Bureau of Industry and Security averaged 38 days per export license application in fiscal year 2023, the most recent data available, denying 2% of 37,943 applications. The license process enforces U.S. export restrictions in an effort to make sure sensitive goods and technology do not reach countries or entities whose use of the items could harm U.S. national security. Some staff have criticized Jeffrey Kessler, who became BIS undersecretary in March, saying he has micromanaged the bureau and failed to communicate adequately. Kessler did not respond to a request for comment. At a staff meeting soon after he took office, Kessler urged BIS staff to limit communications with company representatives and industry officials, according to two additional sources, who said he later asked for all meetings to be entered on a spreadsheet. Getting approval from Kessler's office to attend meetings with other government agencies has also been tricky, those sources said. Sources spoke anonymously because they were not authorized to speak publicly. FRUSTRATION AMONG EXPORTERS Frustration is growing within U.S. industry. 'We're seeing whole sectors where there is no movement or indication if or when licenses will be issued," including license applications for semiconductor manufacturing equipment worth billions of dollars, said Sean Stein, president of the US-China Business Council. While the clock is ticking on license applications, 'Chinese companies are exploring and doing deals with suppliers in China and other countries,' he said. 'The longer we have the delay, the more market share we're going to lose." Jim Anzalone, president of Compliance Assurance, a Florida-based trade consultancy, said he has seen delays in license approvals for sensors, radars, and sonar to Latin America and other parts of the world. 'There's nothing official about what the policy is and when the backlog would be cleared,' he said. He has received denials sporadically after submitting some two dozen applications months ago to export semiconductor manufacturing equipment to China, including four denials on Wednesday, he added. Sources stressed that some licenses are getting approved, especially exports to allied countries, and they noted that some communication with companies continues, especially around license applications. Commerce is also delaying regulatory changes. The agency said in May it would rescind and replace a Biden administration rule before it went into effect that month restricting where AI chips can be exported, but the agency has not done so yet. Other rules, which sources said have been drafted for months, have not been published, including one to expand export restrictions to subsidiaries of companies already banned from receiving controlled U.S. exports. Meanwhile, important staff vacancies such as China-based export control officers have not been filled, and high-level career employees have resigned. A retirement party was held this week for Dan Clutch, acting director of the BIS Office of Export Enforcement, the latest experienced staff member to leave. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Young carers face higher risks of depression, anxiety and lost futures – and most receive no support
Young carers face higher risks of depression, anxiety and lost futures – and most receive no support

Yahoo

time27 minutes ago

  • Yahoo

Young carers face higher risks of depression, anxiety and lost futures – and most receive no support

In developed countries, around 12% of young people provide regular, unpaid care for a family member. It's work that's essential, often invisible – and potentially devastating to their mental health. As more families rely on these young carers, many are left without legal protections, recognition, or the support they urgently need. Across Europe, informal carers now provide up to 80% of all long-term care. This figure is rising sharply due to ageing populations, an increase in chronic illness, and advances in medical technology. Between 2000 and 2050, the demand for unpaid care is expected to grow by 50% in Europe alone, with similar trends emerging in the US and Australia. As adult carers struggle to meet rising demand, children, teenagers and young adults are stepping into the breach. These young carers often take on domestic, emotional, practical and personal care tasks that would challenge any adult. While some report growing resilience, maturity and empathy, the long-term toll on education, mental health and physical wellbeing is increasingly hard to ignore. Lost opportunities, lasting consequences Globally, young carers face significant restrictions on their education and career prospects. In both the UK and Germany, research shows that young adult carers are less likely to complete university, less likely to secure employment and more likely to experience long-term unemployment than their peers. These disadvantages aren't just financial – they're linked to increased rates of depression and anxiety later in life. The social cost is high, too. Young carers are more likely to face bullying, isolation and limited opportunities for friendship or leisure. Chronic illness in the household can increase stress, leading to economic hardship, family breakdown and domestic conflict. Mental health is caught in the crossfire: many young carers experience psychological distress, depression and even self-harm. Along with colleagues, I published a study that underscored the urgency of this issue. Our research showed that young carers in high-income countries are significantly more likely than their peers to experience poor mental health, including anxiety, depression and severe emotional distress. Not all care is equal – and neither are its effects. The intensity, type and duration of caregiving matter greatly. Young carers who provide personal care, dedicate more hours each week, or have cared for a longer period are at the greatest risk of mental health difficulties. Girls and young women are particularly vulnerable. They are overrepresented among young carers and are more likely to take on intensive or prolonged responsibilities. These disparities don't end in childhood. As young adults, female carers tend to experience lower educational attainment and less workforce participation than their male counterparts – disadvantages that have ripple effects on their long-term mental and economic wellbeing. Invisible and unsupported Despite their growing numbers, young carers are often invisible to schools, healthcare providers and policymakers. Most European countries provide no formal recognition, rights or protections. Even though the European parliament addressed the issue in 2018 and 2022, young carers remain absent from key EU frameworks. The UK is a notable exception, with specific rights and national interventions for young carers. But gaps remain. A 2016 report found that nearly one in three young carers identified by local authorities received no support at all. In the US, the situation is worse: a lack of national data means young carers are missing entirely from most political conversations and care agendas. Yet support makes a difference. Studies show that recognition and perceived support, whether from teachers, friends, professionals or government policies, can protect young carers' mental health and improve their long-term outcomes. Support can take many forms: respite care, school accommodations, financial assistance, mentoring, or even a simple acknowledgement that their role matters. Without intervention, the personal and societal costs are substantial: deteriorating mental health, lost educational and career opportunities and increased economic dependency in adulthood. If we fail to support young carers, we fail an entire generation of quiet caregivers – and risk undermining the sustainability of our health and care systems for decades to come. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. This article is republished from The Conversation under a Creative Commons license. Read the original article. Aoife Bowman Grangel receives funding from the Irish Research Council.

Analysis-Trump's 50% Brazil coffee tariff expected to rejig trade, send more beans to China
Analysis-Trump's 50% Brazil coffee tariff expected to rejig trade, send more beans to China

Yahoo

time27 minutes ago

  • Yahoo

Analysis-Trump's 50% Brazil coffee tariff expected to rejig trade, send more beans to China

By Marcelo Teixeira NEW YORK (Reuters) -The Trump administration's steep import tariff on Brazilian coffee looks set to reshuffle trade routes for beans from the world's top grower and exporter, benefiting China and incentivizing traders to look for indirect routes into the U.S. A 50% tariff on some Brazilian products, including coffee, will begin on August 6, the administration of U.S. President Donald Trump said on Wednesday. The move will challenge commodities traders and Brazilian coffee exporters to find buyers for the roughly 8 million bags sold to U.S. coffee processors every year. At around 25 million bags per year, the U.S. is the world's largest coffee consumer. A third of that comes from Brazil, through bilateral trade that was worth $4.4 billion in the 12 months ended in June. "The global coffee trade flow will be reshuffled. The pain will be felt from Sao Paulo to Seattle - from origin to roaster, to cafe chains, grocers, and morning commuters," said Michael J. Nugent, a senior U.S. coffee broker and owner of MJ Nugent & Co. The possible rerouting of the massive volume Brazil usually sends to the U.S., similar to the entire production of high-quality coffee grower Ethiopia, could benefit a major Trump rival: China. More Brazilian beans may be bound for China because of trade ties between the two nations, both members of the BRICS group, and after the first Trump administration disrupted trade, said Marc Schonland, an independent advisor to the U.S. coffee industry. Coffee consumption is surging in China as young professionals drop tea to seek a higher caffeine boost. Brazil is its main supplier, exporting 538,000 bags to China in the first half of 2025, data from exporters association Cecafe showed. Coffee consumption has grown around 20% per year for the last 10 years in China and per capita coffee consumption doubled in the last 5 years, according to industry data. More Brazilian beans could also head to the European Union, where they face no tariffs, said Logan Allender, head of coffee at U.S. roaster and distributor Atlas Coffee Club. Trade experts see possibilities for exporters to try to dodge the tariffs by exporting Brazilian coffee to other countries, and from there to the U.S. "It will add a bit of logistics costs, but brings down the (tariff) effect to a max 10% to 15%," said Debajyoti Bhattacharyya, commercial vice president at agricultural commodities firm AFEX Ltd., adding that countries such as Mexico or Panama could be used for the stopovers. "Without a strong traceable supply chain, tariffs are meaningless. I mean, we can't stop oil from flowing, why would coffee?" he said. Senior soft commodities analyst and independent consultant Judith Ganes said the fact the U.S. left coffee out of an extensive exemption list of Brazilian products suggests Trump is using the product as a bargaining chip in his political quarrel with Brazil's President Luiz Inacio Lula da Silva. Trump has said Brazil's Supreme Court is treating his ally, former Brazilian President Jair Bolsonaro, unfairly. The U.S. sanctioned Supreme Court justice Alexandre de Moraes on Wednesday. Traders said coffee that is loaded in Brazil by August 6 can enter the U.S. without paying the tariff up until October 6. William Kapos, CEO at Downeast Coffee Roasters, a large coffee processor in the U.S. East Coast, said he is rushing to ship Brazilian coffee he has already purchased out of South America before that deadline next week. Going forward, Kapos said he will look to buy coffee from Central America and Africa to replace Brazilian beans. "But everybody will do that, so price-wise it is going to be a squeeze on U.S. buyers," he said. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store